Skip to main content

Advertisement

SpringerLink
Log in

How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Chemotherapy-induced nausea and vomiting (CINV) still remain frequent. The procedure for announcing the diagnosis (PAD) was an emblematic measure of the first French Plan Cancer aiming at providing patients with time to listen, information after cancer diagnosis, and discussion on treatments and their side effects. We aimed at assessing the risk factors of CINV, focusing on patients’ satisfaction with the PAD.

Methods

This prospective multicentre study assessed the frequency and intensity of CINV among chemonaïve patients during the first cycle of treatment. CINV was defined by ≥1 emetic episode or reported nausea intensity ≥3 on a 0–10 scale. Multivariate analysis was used to identify factors related to global CINV onset including satisfaction with the PAD (satisfaction score ≥the median on a 0–10 scale).

Results

Data from 291 patients (women, 85.2 %; mean age, 57 years) were analyzed. Most patients (69.4 %) received highly emetogenic chemotherapy regimens and 77.7 % received antiemetic drugs consistent with international guidelines. Acute, delayed and overall CINV were experienced by 40.4, 34.8 and 52.4 % of patients, respectively. Sixty-seven per cent of patients were satisfied with the PAD. No relation was noted between PAD satisfaction and CINV onset. The nausea and vomiting dimension of the QLQ-C30 questionnaire before chemotherapy (OR 3.62), motion sickness history (OR 2.73), highly emetogenic CT (OR 2.73), anxiety (OR 1.99) and younger age (OR 1.96) were independent predictive factors.

Conclusions

Although patients were mostly satisfied with the PAD, half of them experienced CINV. A state of anxiety could be identified during the PAD to be managed.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Ballatori E, Roila F, Ruggeri B, Betti M, Sarti S, Soru G, Cruciani G, Di MM, Andrea B, Deuson RR (2007) The impact of chemotherapy-induced nausea and vomiting on health-related quality of life. Support Care Cancer 15:179–185

    Article  PubMed  Google Scholar 

  2. Fernandez-Ortega P, Caloto MT, Chirveches E, Marquilles R, Francisco JS, Quesada A, Suarez C, Zorrilla I, Gomez J, Zabaleta P, Nocea G, Llombart-Cussac A (2012) Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients’ quality of life. Support Care Cancer 20:3141–3148

    Article  CAS  PubMed  Google Scholar 

  3. Molassiotis A, Aapro M, Dicato M, Gascon P, Novoa SA, Isambert N, Burke TA, Gu A, Roila F (2014) Evaluation of risk factors predicting chemotherapy-related nausea and vomiting: results from a European prospective observational study. J Pain Symptom Manage 47:839–848

    Article  PubMed  Google Scholar 

  4. Roscoe JA, Bushunow P, Morrow GR, Hickok JT, Kuebler PJ, Jacobs A, Banerjee TK (2004) Patient expectation is a strong predictor of severe nausea after chemotherapy: a University of Rochester Community Clinical Oncology Program study of patients with breast carcinoma. Cancer 101:2701–2708

    Article  PubMed  Google Scholar 

  5. Montgomery GH, Bovbjerg DH (2000) Pre-infusion expectations predict post-treatment nausea during repeated adjuvant chemotherapy infusions for breast cancer. Br J Health Psychol 5:105–119

    Article  Google Scholar 

  6. Institut national du cancer F (2005) Recommandations nationales pour la mise en oeuvre du dispositif d’annonce du cancer dans les établissements de santé, élaborées par l’INCa et la Ligue contre le cancer

    Google Scholar 

  7. Waller A, Forshaw K, Bryant J, Mair S (2014) Interventions for preparing patients for chemotherapy and radiotherapy: a systematic review. Support Care Cancer 22:2297–2308

    Article  PubMed  Google Scholar 

  8. Molassiotis A, Coventry PA, Stricker CT, Clements C, Eaby B, Velders L, Rittenberg C, Gralla RJ (2007) Validation and psychometric assessment of a short clinical scale to measure chemotherapy-induced nausea and vomiting: the MASCC antiemesis tool. J Pain Symptom Manage 34:148–159

    Article  PubMed  Google Scholar 

  9. Molassiotis A, Stamataki Z, Kontopantelis E (2013) Development and preliminary validation of a risk prediction model for chemotherapy-related nausea and vomiting. Support Care Cancer 21:2759–2767

    Article  CAS  PubMed  Google Scholar 

  10. Roila F, Herrstedt J, Aapro M, Gralla RJ, Einhorn LH, Ballatori E, Bria E, Clark-Snow RA, Espersen BT, Feyer P, Grunberg SM, Hesketh PJ, Jordan K, Kris MG, Maranzano E, Molassiotis A, Morrow G, Olver I, Rapoport BL, Rittenberg C, Saito M, Tonato M, Warr D (2010) Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference. Ann Oncol 21(Suppl 5):v232–v243

    Article  PubMed  Google Scholar 

  11. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, de Haes JC (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85:365–376

    Article  CAS  PubMed  Google Scholar 

  12. Razavi D, Delvaux N, Farvacques C, Robaye E (1989) Validation de la version française du HADS dans une population de patients cancéreux hospitalisés. Revue de psychologie appliquée

    Google Scholar 

  13. Gilmore JW, Peacock NW, Gu A, Szabo S, Rammage M, Sharpe J, Haislip ST, Perry T, Boozan TL, Meador K, Cao X, Burke TA (2014) Antiemetic guideline consistency and incidence of chemotherapy-induced nausea and vomiting in US community oncology practice: INSPIRE Study. J Oncol Pract 10:68–74

    Article  PubMed  Google Scholar 

  14. Hesketh PJ, Grunberg SM, Gralla RJ, Warr DG, Roila F, de Wit R, Chawla SP, Carides AD, Ianus J, Elmer ME, Evans JK, Beck K, Reines S, Horgan KJ (2003) The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin–the Aprepitant Protocol 052 Study Group. J Clin Oncol 21:4112–4119

    Article  CAS  PubMed  Google Scholar 

  15. Booth CM, Clemons M, Dranitsaris G, Joy A, Young S, Callaghan W, Trudeau M, Petrella T (2007) Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study. J Support Oncol 5:374–380

    PubMed  Google Scholar 

  16. Molassiotis A, Yam BM, Yung H, Chan FY, Mok TS (2002) Pretreatment factors predicting the development of postchemotherapy nausea and vomiting in Chinese breast cancer patients. Support Care Cancer 10:139–145

    Article  CAS  PubMed  Google Scholar 

  17. Institut national du cancer F, La Ligue contre la cancer F, Direction générale de l’offre des soins F. Étude sur l’annonce du diagnostic de cancer et le ressenti des malades en 2011. 1-5-2012.

  18. Farrell C, Brearley SG, Pilling M, Molassiotis A (2013) The impact of chemotherapy-related nausea on patients’ nutritional status, psychological distress and quality of life. Support Care Cancer 21:59–66

    Article  PubMed  Google Scholar 

  19. Stafford L, Thomas N, Foley E, Judd F, Gibson P, Komiti A, Couper J, Kiropoulos L (2015) Comparison of the acceptability and benefits of two mindfulness-based interventions in women with breast or gynecologic cancer: a pilot study. Support Care Cancer 23:1063–1071

    Article  PubMed  Google Scholar 

  20. Andersen BL, DeRubeis RJ, Berman BS, Gruman J, Champion VL, Massie MJ, Holland JC, Partridge AH, Bak K, Somerfield MR, Rowland JH (2014) Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol 32:1605–1619

    Article  PubMed Central  PubMed  Google Scholar 

  21. Pirl WF, Fann JR, Greer JA, Braun I, Deshields T, Fulcher C, Harvey E, Holland J, Kennedy V, Lazenby M, Wagner L, Underhill M, Walker DK, Zabora J, Zebrack B, Bardwell WA (2014) Recommendations for the implementation of distress screening programs in cancer centers: report from the American Psychosocial Oncology Society (APOS), Association of Oncology Social Work (AOSW), and Oncology Nursing Society (ONS) joint task force. Cancer 120:2946–2954

    Article  PubMed  Google Scholar 

  22. Ezzo JM, Richardson MA, Vickers A, Allen C, Dibble SL, Issell BF, Lao L, Pearl M, Ramirez G, Roscoe J, Shen J, Shivnan JC, Streitberger K, Treish I, Zhang G (2006) Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev 2:CD002285

  23. Karagozoglu S, Tekyasar F, Yilmaz FA (2013) Effects of music therapy and guided visual imagery on chemotherapy-induced anxiety and nausea-vomiting. J Clin Nurs 22:39–50

    Article  PubMed  Google Scholar 

  24. Lin MF, Hsieh YJ, Hsu YY, Fetzer S, Hsu MC (2011) A randomised controlled trial of the effect of music therapy and verbal relaxation on chemotherapy-induced anxiety. J Clin Nurs 20:988–999

    Article  PubMed  Google Scholar 

  25. Lotfi-Jam K, Carey M, Jefford M, Schofield P, Charleson C, Aranda S (2008) Nonpharmacologic strategies for managing common chemotherapy adverse effects: a systematic review. J Clin Oncol 26:5618–5629

    Article  PubMed  Google Scholar 

Download references

Acknowledgments

This study was supported by a grant from the Ligue Contre le Cancer, France, and MSD-France (Merck Sharp and Dohme). We would like to thank Ray Cooke for help in language and content editing of this manuscript.

Author information

Authors and Affiliations

  1. Centre François Baclesse, Department of Oncology, Caen, France

    Julie Vanbockstael, Elodie Coquan, Djelila Allouache, Audrey Faveyrial, Sabine Noal, Corinne Delcambre, Marie-Pierre Galais, Jean-François Héron, Anne-Charlotte Lefebvre, Emmanuel Sevin, Ioana Hrab, Florence Polycarpe, Radj Gervais & Katharina Gunzer

  2. Rouen University Hospital, Department of Oncology, Rouen, France

    Sophie Gouerant

  3. Hôpital Monod, Department of Oncology, Flers, France

    Michel André & Gilles Saucier

  4. Centre Hospitalier Public du Cotentin, Department of Oncology, Cherbourg-Octeville, France

    Laure Kaluzinski

  5. Clinique Armoricaine, Department of Oncology, Saint-Brieuc, France

    Brigitte Vié

  6. Centre François Baclesse, Clinical Research Department, av général Harris, Caen, 14000, France

    Elodie Coquan, Noëmie Lemenand, Jean-Michel Grellard, Bénédicte Clarisse, Audrey Emmanuelle Dugué & Florence Joly

  7. Université de Caen Basse-Normandie, UMR-S1077, Caen, France

    Florence Joly

  8. INSERM, U1086, Caen, France

    Florence Joly

  9. CHU de Caen, Department of Oncology, Caen, France

    Florence Joly

  10. Centre Henri Becquerel, Department of Oncology, Rouen, France

    Sophie Gouerant

Authors
  1. Julie Vanbockstael
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elodie Coquan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Sophie Gouerant
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Djelila Allouache
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Audrey Faveyrial
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Sabine Noal
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Corinne Delcambre
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Marie-Pierre Galais
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jean-François Héron
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Anne-Charlotte Lefebvre
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Emmanuel Sevin
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Ioana Hrab
    View author publications

    You can also search for this author in PubMed Google Scholar

  13. Florence Polycarpe
    View author publications

    You can also search for this author in PubMed Google Scholar

  14. Michel André
    View author publications

    You can also search for this author in PubMed Google Scholar

  15. Laure Kaluzinski
    View author publications

    You can also search for this author in PubMed Google Scholar

  16. Radj Gervais
    View author publications

    You can also search for this author in PubMed Google Scholar

  17. Katharina Gunzer
    View author publications

    You can also search for this author in PubMed Google Scholar

  18. Brigitte Vié
    View author publications

    You can also search for this author in PubMed Google Scholar

  19. Gilles Saucier
    View author publications

    You can also search for this author in PubMed Google Scholar

  20. Noëmie Lemenand
    View author publications

    You can also search for this author in PubMed Google Scholar

  21. Jean-Michel Grellard
    View author publications

    You can also search for this author in PubMed Google Scholar

  22. Bénédicte Clarisse
    View author publications

    You can also search for this author in PubMed Google Scholar

  23. Audrey Emmanuelle Dugué
    View author publications

    You can also search for this author in PubMed Google Scholar

  24. Florence Joly
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Elodie Coquan.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Vanbockstael, J., Coquan, E., Gouerant, S. et al. How to improve the prevention of chemotherapy-induced nausea and vomiting? The French NAVI study. Support Care Cancer 24, 1131–1138 (2016). https://doi.org/10.1007/s00520-015-2882-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-015-2882-7

Keywords

Search

Navigation